Is Invesco RAFI Emerging Markets ETF (PXH) a Strong ETF Right Now?

The Invesco RAFI Emerging Markets ETF (PXH), a smart beta fund with over $1.54 billion AUM, tracks the FTSE RAFI Emerging Markets Index by fundamentally weighting emerging market equities based on metrics like book value and cash flow. PXH has demonstrated robust performance, returning 19.06% year-to-date and 25.26% over the past 12 months (as of 08/11/2025), while maintaining a medium-risk profile. However, its 0.47% expense ratio stands significantly higher than traditional market-cap weighted peers such as Vanguard FTSE Emerging Markets ETF (VWO) at 0.07% and iShares Core MSCI Emerging Markets ETF (IEMG) at 0.09%, presenting a trade-off between its active selection methodology and cost efficiency for institutional investors.

Analysis

The Invesco RAFI Emerging Markets ETF (PXH) is a smart beta fund with $1.54 billion in assets, offering exposure to emerging markets through a non-market-cap-weighted strategy. The fund's index selects and weights equities based on four fundamental measures: book value, cash flow, sales, and dividends. This methodology has contributed to strong recent performance, with the ETF delivering a 19.06% year-to-date return and a 25.26% gain over the last 12 months as of August 11, 2025. From a risk perspective, PXH exhibits a beta of 0.57 and a three-year standard deviation of 17.81%, positioning it as a medium-risk option with lower volatility than the broader market. The fund also offers a notable 12-month trailing dividend yield of 3.40%. However, its primary drawback is its cost structure; the 0.47% annual expense ratio is substantially higher than those of large, passive competitors like the Vanguard FTSE Emerging Markets ETF (VWO) at 0.07% and the iShares Core MSCI Emerging Markets ETF (IEMG) at 0.09%. While diversified across 439 holdings, the top ten constituents, including Taiwan Semiconductor and Alibaba, account for a meaningful 29.85% of total assets.

Key Decisions for Investors

• Investors seeking fundamentally-driven emerging market exposure may find PXH's recent outperformance and 3.40% dividend yield attractive, warranting consideration for portfolios focused on value and income.
• Cost-conscious investors should carefully evaluate if the fund's potential for alpha justifies its 0.47% expense ratio, which is significantly higher than passive market-cap weighted alternatives like VWO and IEMG.
• Given its beta of 0.57, PXH could be used to gain emerging markets exposure with potentially lower volatility, but continued monitoring is required to ensure its active strategy consistently overcomes its fee drag relative to passive indices.